MTMR9 antisense RNA 1 (MTMR9-AS1)

MTMR9 antisense RNA 1 (MTMR9-AS1) is a long non-coding RNA (lncRNA) transcribed from the antisense strand of the MTMR9 gene locus. Antisense lncRNAs typically regulate the expression of their corresponding sense genes through mechanisms such as RNA-RNA duplex formation, recruitment of RNA-binding proteins, or affecting mRNA stability[2][3][5]. While antisense lncRNAs are increasingly implicated in cancer, cell proliferation, and gene regulation, there is currently no published evidence directly describing the molecular function, disease role, or drug interactors of MTMR9-AS1 specifically. Thus, its biological and clinical significance remains undetermined. Additional context about antisense lncRNAs: - They often regulate gene expression in cis (at their own locus) or in trans (elsewhere in the genome)[3][5]. - Mechanisms include affecting mRNA stability, interfering with translation, or recruiting epigenetic modifiers[2][3]. - Antisense lncRNAs for other genes have been shown to modulate cancer biology and cell signaling, but such data for MTMR9-AS1 is lacking. Summary: MTMR9-AS1 is a putative regulatory non-coding RNA without current evidence of being a direct therapeutic target, biomarker, or disease gene. It is not currently associated with any drugs, disease mechanisms, or well-defined biological pathways. The designation "MTMR9 antisense RNA 1" as a therapeutic target is likely incorrect at present due to lack of validated data.

Other names

MTMR9-AS1